DB Drugs Flashcards

1
Q

Clues a patient has T1DM

A

Young ,slender, sudden onset, DKA (ketoacidosis), undx levels of C-peptide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tx a person in T1DM with ketoacidosis

A

Premeal rapid-acting insulin (aspart) with glargine at bed time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Tx a T1DM pt and in an emergent situation

A

give regular insulin bc only one that can be given via IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

________ can precipitate if there is a change in body temperature /pkA

A

insulin glargine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MOA of insulin

A
  1. binds to receptor
    • P13K-AKT pathway (phosphoinositude -3 - kinase)
      1. makes lipids, fats and glycogen
      2. puts GLUT4 on cell surface
    • MAPK pathway
      1. gene transcription and cell proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Insulin is an anabolic hormone and does what

A
  1. moves GLUT 4 on membrane
    • glycolysis and glycogen synthesis
  2. Inhibits gluconeogenesis and glycogenolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

most imp electrolyte to watch in T1DM on insulin therapy

A
  1. K+: bc insulin moves Na/K+ATPase on membrane and moves K+ into cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when is hyperkalemia most common

A

T1DM pt with DKA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do we see in patient with DKA

A
  1. insulin def
  2. Acidosis
  3. Hyperosmolarity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pt has T2DM and takes a drug that causes hypoglycemia. what is the most common

A
  1. Sulfonylrurea drugs and meglitinide drugs (insulin secreting drugs)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Highest risk of hypoglycemia

A

insulin (T1DM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Moderate risk of hypoglycemia

A
  1. Sulfonylurea/ non-sulfonurea drugs = insulin secreting
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Low risk of hypoglycemia

A

Glucose-dependent insulinotropism drugs = do not induce the release of insulin themselves; they enhance the release of insulin when hyperglycemic d/t ATP

  1. DDP-4 inhibitors
  2. GLP-1 AGO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Euglycemic drugs (ONLY decrease levels of glucose in HYPERGLYCEMIC pt; not in a person with NL glucose levels)

A
  • 1. Biguanides
  • 2. SGLT2-I
  • 3. Alpha-glycosidase inhibitors
  • 4. Thiazoladindiones

Does cause hypoglycemia when taking w other drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Glucose-dependent insulinotropism drugs

A

those that enhance ther release of insulin when pt is HYPERGLYCEMIC d/t ATP; does not release it themselves

  1. DDP4-I
  2. GLP-receptor AGO
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Which drugs with T2DM will prevent WG?

A
  1. SGLT-2 inhibitors (-gliflozins)
    1. canagliflozin
    2. depagliflozin
    3. rampagliflozin
17
Q

T2DM pts who are obsese/ gaining weight should avoid what drugs?

A

1. Insulin

2. TZDs

3. Sulfonurea/meglitinides

18
Q

What drugs cause WL

A
  1. Metaformin
  2. SGLT2-I
  3. DDP-4 I
  4. GLP-1 AGO
19
Q

effects of SLGT2-I (gliflozins)

A
  1. osmotic diuresis
  2. WL
  3. Decrease BP

4. Loss of uric acids

20
Q

T1DM who is hypoglycemic is often due to

A

Insulin OD

Skipped meal/late meal

21
Q

MCC of T2DB w hypoglycemia

A

Sulfonurea/meglinitiines

22
Q

Tx of T1DM pt with hypoglycemia

A
  1. Glucose
  2. Glucagon (SQ): + Gs => + AC => + pKA => glycogenolysis and gluconeogenesis

3.

23
Q

Tx of T2DM hypoglycemia due to sulfonureas

A
    1. Glucose
  • 2. Octreotide (somatostatin- r ANT => inhibits release of insulin)
  • 3. Diazoxide: + Katp channels on B-cell => inhibits the release of insulin
  • 4. Glucagon